Law Practice
Sep. 6, 2007
Drug Cases Cause Surge in San Francisco Civil Filings
SAN FRANCISCO - The Merck Vioxx litigation in Los Angeles has gotten a lot of attention in the last year. But L.A. doesn't have the market cornered when it comes to massive pharmaceutical cases.
Daily Journal Staff Writer
SAN FRANCISCO - The Merck Vioxx litigation in Los Angeles has gotten a lot of attention in the last year. But L.A. doesn't have the market cornered when it comes to massive pharmaceutical cases.
According to recently released statistics, civil filings in San Francisco's federal court shot up 46 percent last year, far more than in the state's...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In